【問題】Excipients ?推薦回答

關於「Excipients」標籤,搜尋引擎有相關的訊息討論:

Excipients labelling | European Medicines Agency。

2021年7月20日 · EU guideline · Excipients with a known action or effect · Timeline for implementing revisions · Background information on individual excipients.: tw | tw。

Annex to the European Commission guideline on 'Excipients in the ...。

Annex to the European Commission guideline on 'Excipients in labelling and package leaflet of medicinal products for human use': tw | tw。

[PDF] Handbook of Pharmaceutical Excipients。

Smolinske SC. Handbook of Food, Drug and Cosmetic. Excipients. Boca Raton, FL: CRC Press, 1992. Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical.。

Three-dimensional aspects of formulation excipients in drug discovery。

2020年2月2日 · PDF | Formulation/pharmaceutical excipients play a major role in ... ethanol, N-methyl-2-pyrrolidone, propylene glycol, PEG400, and PEG300), ...。

Reactive Impurities in Excipients: Profiling, Identification and ... - NCBI。

2011年9月27日 · Reactive impurities in pharmaceutical excipients could cause drug product ... Waterman K, Arikpo WB, Fergione MB, Graul TW, Johnson BA, ...。

Excipients in the Paediatric Population: A Review | HTML - MDPI。

Preparations were recorded with ethanol, propylene glycol, benzyl alcohol, parabens, aspartame, glycerol, sorbitol and polysorbate-80 and cumulative amounts [24] ...: tw | tw。

Excipient Applications in Formulation Design and Drug Delivery。

Benet LZ, Amidon GL, Barends DM, Lennernas H, Polli JE, Shah VP, ... Int J Pharm 126(1–2):267–274 Chin TW, Loeb M, Fong IW (1995) Effects of an acidic ...。

Role of Lipid Excipients in Modifying Oral and Parenteral Drug ...。

Yi, S.M., Yune, T.Y., Kim, T.W., Chung, H., Choi, Y.W., Kwon, I.C., et al. ... Balakrishnan, A., Rege, B.D., Amidon, G.L., Polli, J.E. Surfactant-mediated ...。

Profiles of Drug Substances, Excipients and Related Methodology。

Schaad - Lanyi, Z., Dieterle, W., Dubois, J. P., Vischer, T. W. (1987). Int. J. Lepr. ... Woods, G. L., and Washington, J. A. (1987). Rev. Infect. Dis.。

Nonclinical Studies for the Safety Evaluation of Pharmaceutical。

2018年8月24日 · This document provides guidance concerning development of safety profiles to support use of new excipients as components of drug or ...:


常見Excipients問答


延伸文章資訊